Overexpression of receptors such as EGFR, transforming growth factor beta (TGFβ) receptor, c-met, and tropomyosin receptor kinase B (TrkB), and growth factors such as EGF, TGF, HGF, and BDNF have been found to drive aggressive and resistant cancer phenotypes. Here, EGFR is linked to cancer.